While High concentrations of succinate in the tumor microenvironment are taken up by T cells, suppressing glucose flux through the TCA cycle, this, in conjunction with SUCNR1 signaling, inhibits T cell functions (321). The gene discussed is SUCNR1; the disease is neoplasm.